Liridon Rrushaj

Liridon Rrushaj is a professional with experience in venture investing and healthcare strategy. Currently serving as a Board Observer at Cala Health, Cardiosense, and Epitel, Liridon also holds the position of Director of Venture Investing at OSF HealthCare. Prior experience includes working as a Healthcare Strategy Consultant at Accenture. Liridon Rrushaj holds a Bachelor of Science (B.Sc.) in Industrial Engineering from Northwestern University and has further education from the University of Virginia Darden School of Business.